Roche expands automated mass spectrometry menu
The fully automated solution replaces labor-intensive manual workflows, reducing turnaround times and supporting faster, standardized, high-quality care
The fully automated solution replaces labor-intensive manual workflows, reducing turnaround times and supporting faster, standardized, high-quality care
The new PCR test aids in the diagnosis of infectious causes of vaginitis through the detection of bacteria associated with bacterial vaginosis and yeast associated with candida vaginitis
New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helping clinicians distinguish dengue from other acute fever-causing illnesses
An exclusive interview with Dr. Benjamin Lilienfeld on advancements, precision, and personalized care in vitamin D testing
Recently granted CE Mark, the novel test delivers improved sensitivity and accuracy for faster and more reliable diagnosis in emergencies
Roche's achievement marks an important step in broadening the clinical utility of mass spectrometry testing across routine labs
The VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment
Roche Diagnostics leadership answers questions around cobas® mass spectrometry solution launch
Guest editorial by Dr. Benjamin Lilienfeld, Lifecycle Leader Serum Work Area Systems, Senior Vice President, Roche
Discover the latest cutting-edge technology from Roche at the American Association of Clinical Chemistry 2023 Clinical Lab Expo